We invest in unique solutions and business models that offer a sustainable competitive advantage, with international potential and scalability. In most cases, these are important prerequisites needed to create long-term profitability. Another key investment criterion is a skilled and committed management team that is, or wants to be, co-owners.

Life Science investments

Enabling industrial development
SEB Venture Capital's first Life Science investments were made in 1999. Since then, a total of 27 have been made, of which 20 have been divested to major industry players such as Astra Zeneca, Johnson & Johnson and Biovitrum as well as through IPOs in Stockholm and London.

Technology investments

Advanced technologies require visionary capital
Since SEB Venture Capital was established in 1995, we have made 50 investments in the technology sector, of which 32 have been divested. Our investments range from fundamental industrial technology to the development of application software.